The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex multi-step synthetic process. Preliminary routes focused on protein fragment coupling, utilizing https://umartrio041535.blogdal.com/41127567/creation-and-investigation-implementations-of-retatrutide